TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses.
Mandilaras V, Garg S, Cabanero M, Tan Q, Pastrello C, Burnier J, Karakasis K, Wang L, Dhani NC, Butler MO, Bedard PL, Siu LL, Clarke B, Shaw PA, Stockley T, Jurisica I, Oza AM, Lheureux S.
Mandilaras V, et al. Among authors: oza am.
Int J Gynecol Cancer. 2019 Feb;29(2):346-352. doi: 10.1136/ijgc-2018-000087. Epub 2019 Jan 18.
Int J Gynecol Cancer. 2019.
PMID: 30659026